Founded with a mission to revolutionize disease tracking and therapy management, Injectsense provides ultra-miniature sensors that offer continuous, clinically actionable information. Their core product is an injectable sensor that integrates with a secure digital health platform, enabling real-time monitoring of progressive disease indicators. This technology aims to improve patient outcomes by ensuring that critical health data is always available to healthcare providers, regardless of the patient's location.
Injectsense is supported by a team of engineers and scientists specializing in semiconductor and medical systems industries. The company has garnered attention for its innovative approach to digital health, attracting notable investors and advisors from the healthcare and technology sectors. Their key achievements include the successful development and deployment of their implantable sensors, which have shown significant potential in enhancing disease management and patient care.
